Connect with:
Sunday / December 22. 2024
HomePosts Tagged "CEO & MD"

Company’s Profit After Tax stood at Rs. 538.310 million in Q2FY25.

Praj Industries (Praj), announced its unaudited financial results for the quarter ended Sept 30, 2024.Company’s income from operations stood at Rs. 8,161.920 million in Q2FY25 (Q1 FY25: Rs. 6,991.414 million; Q2 FY24: Rs 8,823.685 million). Company reported Profit Before Tax (PBT) Rs 744.419 million for the period (Q1 FY25: Rs. 788.805 million; Q2 FY24: Rs 848.121 million). Company’s Profit After Tax is at Rs. 538.310 million in Q2FY25 (Q1 FY25: Rs. 841.807 million; Q2 FY24: 623.679 million). Order intake during the quarter Rs. 9,210 million (Q1 FY25: 8,880 million; Q2 FY24: Rs. 10,630 million)

In H1FY25 Company’s Income from operations stood at Rs. 15,153.334 million (H1 FY24: Rs. 16,190.912 million). Company’s PBT before exceptional items is at Rs. 1,533.224 million for the period (H1 FY24: Rs. 1,625.154 million). PBT after exceptional items Rs. 1,814.796 million. In H1FY25 company’s PAT stood at Rs. 1,380.117 million (H1 FY24: Rs. 1,210.405 million). Order intake Rs.18,090 million (H1 FY24: Rs. 21,640 million)

Commenting on the Company’s performance, Shishir Joshipura, CEO & MD, Praj Industries said, “The Bioenergy segment continues to develop positively as we witness our business growing in multiple dimensions, with healthy order and enquiry inflows from international, services and engineering verticals in the first half of the year. Several positive developments in the ecosystem and market augur well for continued growth journey as we move forward. Commissioning of our Demo plant for biopolymers opens a completely new dimension in form of renewable chemicals and materials segment. Our strong focus on R&D backed solutions will continue help us stay on our envisioned growth path”.

Key Developments:

 Inauguration of India’s first-of-its-kind Demo Facility for Biopolymers, showcasing indigenously developed integrated Polylactic Acid (PLA) technology at the hands of Union Minister, Dr Jitendra Singh, Ministry of Science & Technology, in the presence of Dr Rajesh Gokhale, Secretary, Dept. of Biotechnology (DBT) and Dr. Ashish Lele (NCL).

Company’s Profit After Tax stood at Rs.

Company reports Rs 8,286.226 million incomes from operations in Q3 FY24.

Praj Industries (Praj) announced its unaudited financial results for the quarter and nine months ended Dec 31, 2023. Income from operations stood at Rs. 8,286.226 million (Q2 FY24: Rs. 8,823.685 million; Q3 FY23: Rs ,114.647 million). Company’s Profit Before Tax stood at Rs 919.217 million for the period (Q2 FY24: Rs. 848.121 million; Q3 FY23: Rs. 858.997 million).  Profit After Tax is at Rs. 704.143 million (Q2 FY24: Rs. 623.679 million; Q3 FY23: 623.113 million). Order intake during the quarter Rs 10,370 million (Q2 FY24: 10,630 million; Q3 FY23: Rs. 9,440 million) 

Performance Review for 9M FY24 ‐ Consolidated:

  • Income from operations stood at Rs. 24,477.138 million (9M FY23: Rs. 25,240.533 million) 
  • PBT is at Rs. 2,544.371 million for the period (9M FY23: Rs. 2,059.116 million)
  • PAT is at Rs. 1,914.548 million (9M FY23: Rs. 1,517.031 million)
  • Order intake Rs. 32,010 million (9M FY23: Rs. 30,190 million)

The consolidated order backlog as on December 31, 2023 stood at Rs 39,500 million which comprises of 75 per cent domestic orders and 25 per cent international orders.

Commenting on the Company’s performance, Shishir Joshipura, CEO & MD, Praj Industries said, “The quarter saw positive business development in new growth areas identified.  The policy restriction on the use of sugar syrup as feedstock created a near‐term challenge in the market. Praj has already developed solutions for mitigating the feedstock challenge for our customers and we are confident that these solutions will help restore the opportunity next year.  Our Mangalore facility is developing along the planned lines and the business pipeline to feed this facility is also growing stronger.”

Company reports Rs 8,286.226 million incomes from

Company records Rs. 623.679 million PAT in Q2FY 24 compared to Rs. 657.778 million PAT in Q2 FY23.

Pune based Praj Industries (Praj), announced its unaudited financial results for the quarter ended Sept 30, 2023. Praj, India’s most accomplished industrial biotechnology company is driven by innovation, integration and delivery capabilities. Over the past four decades, Praj has focused on the environment, energy, and agri-process industry, with 1000++ customer references spanning 100+ countries across all 5 continents.

Performance Review for Q2 FY24 – Consolidated:

• Income from operations stood at Rs. 8,823.685 million (Q1 FY24: Rs. 7,367.227 million; Q2 FY23: Rs. 8,806.172 million)

• PBT is at Rs. 848.121 million for the period (Q1 FY24: Rs. 777.033 million; Q2 FY23: Rs. 657.778 million)

• PAT is at Rs. 623.679 million (Q1 FY24: Rs. 586.726 million; Q2 FY23: 481.286 million)

• Order intake during the quarter Rs. 10,630 million (Q1 FY24: 11,010 million; Q2 FY23: Rs. 9,810 million)

Performance Review for H1 FY24 – Consolidated:

• Income from operations stood at Rs. 16,190.912 million (H1 FY23: Rs. 16,125.886 million)

• PBT is at Rs. 1,625.154 million for the period (H1 FY23: Rs. 1200.119 million)

• PAT is at Rs. 1,210.405 million (H1 FY23: Rs. 893.918 million)

• Order intake Rs.21,640 million (H1 FY23: Rs. 20,750 million)

Commenting on the Company’s performance, Shishir Joshipura, CEO & MD, Praj Industries said, “The quarter witnessed development of business activity on similar lines as first quarter. Domestic markets witnessed a brief period of reduced activity as the grain policy changes unfolded before returning to normalcy. The launch of Global Biofuels Alliance is expected to provide a new platform for opportunities across domestic and international markets in medium to long term”.

Company records Rs. 623.679 million PAT in